Inhibikase Therapeutics Inc (IKT)
SG&A Expense Growth
3.82%
Quarterly · Period ending:
IKT SG&A Expense Growth
Latest reported3.82%period ending
Latest reported3.82%period ending
IKT Quarterly SG&A Growth (QoQ) (0.00% → 3.82%)
Latest values, visible window
High-resolution chart · PNG
IKT sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 3.8151% | |
| 8.8798% | |
| 20.7262% | |
| -5.2068% | |
| 12.772% | |
| -8.4713% | |
| 250.2152% | |
| -17.071% | |
| -2.4602% | |
| 45.2284% | |
| -13.7538% | |
| -0.467% | |
| -15.435% | |
| 43.3772% | |
| -12.8633% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| -47.1292% | |
| 164.5218% | |
| -32.8108% | |
| 0% | |
| 52.7384% | |
| 0% | |
| 0% |